Fully booked! China braces for record May Day holiday rush

By Sophie Yu and Brenda Goh BEIJING (Reuters) – China is bracing for a record-high travel rush over the Labour Day holiday, with popular sightseeing spots selling out of tickets and some cities warning would-be visitors away as domestic tourism rebounds after Beijing ended COVID curbs. Authorities are expecting 19 million trips to be made…

Read More

Sudan’s factions say they agree to extend truce but fighting goes on

By Khaled Abdelaziz and Nafisa Eltahir KHARTOUM (Reuters) -Sudan’s two warring factions said on Thursday they would prolong a ceasefire agreement by 72 hours, but violence again rocked the capital Khartoum and the western region of Darfur as the U.S. said ceasefire violations were worrying.  Hundreds have died and tens of thousands of people have…

Read More

Gilead profit misses Wall Street expectations as COVID drug sales decline

(Reuters) -Gilead Sciences Inc on Thursday reported a lower-than-expected first-quarter profit as sales from COVID-19 antiviral Veklury declined more than anticipated, and its shares fell more than 2%. Sales of the hospital-administered drug also know as remdesivir plunged 63% to $573 million for the quarter, well off analysts’ estimates of $697.6 million. The company said…

Read More

US to dedicate specially trained asylum officers to centers in Guatemala, Colombia

WASHINGTON (Reuters) – The United States will dedicate specially trained asylum officers to new refugee centers in Guatemala and Colombia, Department of Homeland Security Secretary Alejandro Mayorkas told reporters on Thursday as Washington seeks to create new lawful pathways for migrants. The announcement was part of a series of actions rolled out by President Joe…

Read More

Court revives charges over COVID-19 outbreak at Massachusetts veterans’ home

By Nate Raymond and Brendan Pierson (Reuters) – Massachusetts’ top court on Thursday revived the indictments against two former leaders of a veterans’ home charged with criminal neglect for their roles in handling a COVID-19 outbreak that killed 84 people. The Massachusetts Supreme Judicial Court, in a 5-2 ruling, overturned a judge’s decision to throw…

Read More

AbbVie posts weak sales of newer drugs as Humira faces fresh competition, shares fall

By Patrick Wingrove and Leroy Leo (Reuters) -AbbVie Inc on Thursday missed quarterly revenue estimates for its newer treatments, fueling concerns over the drugmaker’s attempts to cushion the blow to sales from fresh competition for its flagship arthritis drug Humira. The company’s shares tumbled more than 8% as investors shrugged off a raised full-year profit…

Read More